Patiromer Enables The Initiation Of Mineralocorticoid Receptor Antagonists (MRAs) For Heart Failure With Reduced Ejection Fraction (HFrEF) In Patients With Hyperkalemia (HK) Or Previous HK: Post HocAnalysis Of The DIAMOND Trial
JOURNAL OF CARDIAC FAILURE（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要